Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Operating Margin (2016 - 2025)

Firefly Neuroscience has reported Operating Margin over the past 15 years, most recently at 607.04% for Q4 2025.

  • Quarterly results put Operating Margin at 607.04% for Q4 2025, up 587598.0% from a year ago — trailing twelve months through Dec 2025 was 775.48% (up 853378.0% YoY), and the annual figure for FY2025 was 775.48%, up 853378.0%.
  • Operating Margin for Q4 2025 was 607.04% at Firefly Neuroscience, up from 684.54% in the prior quarter.
  • Over the last five years, Operating Margin for AIFF hit a ceiling of 24.36% in Q2 2023 and a floor of 12933.33% in Q3 2024.
  • Median Operating Margin over the past 5 years was 165.55% (2023), compared with a mean of 2680.46%.
  • Biggest five-year swings in Operating Margin: plummeted -1261436bps in 2024 and later skyrocketed 1224880bps in 2025.
  • Firefly Neuroscience's Operating Margin stood at 1.96% in 2021, then crashed by -2522bps to 51.38% in 2022, then crashed by -222bps to 165.55% in 2023, then crashed by -3816bps to 6483.02% in 2024, then skyrocketed by 91bps to 607.04% in 2025.
  • The last three reported values for Operating Margin were 607.04% (Q4 2025), 684.54% (Q3 2025), and 546.49% (Q2 2025) per Business Quant data.